285 related articles for article (PubMed ID: 11302869)
1. Glandular and extraglandular expression of costimulatory molecules in patients with Sjögren's syndrome.
Matsumura R; Umemiya K; Goto T; Nakazawa T; Kagami M; Tomioka H; Tanabe E; Sugiyama T; Sueishi M
Ann Rheum Dis; 2001 May; 60(5):473-82. PubMed ID: 11302869
[TBL] [Abstract][Full Text] [Related]
2. Possible function of salivary gland epithelial cells as nonprofessional antigen-presenting cells in the development of Sjögren's syndrome.
Tsunawaki S; Nakamura S; Ohyama Y; Sasaki M; Ikebe-Hiroki A; Hiraki A; Kadena T; Kawamura E; Kumamaru W; Shinohara M; Shirasuna K
J Rheumatol; 2002 Sep; 29(9):1884-96. PubMed ID: 12233883
[TBL] [Abstract][Full Text] [Related]
3. Glandular and extraglandular expression of the Fas-Fas ligand and apoptosis in patients with Sjögren's syndrome.
Matsumura R; Umemiya K; Kagami M; Tomioka H; Tanabe E; Sugiyama T; Sueishi M; Nakajima A; Azuma M; Okumura K; Sumida T
Clin Exp Rheumatol; 1998; 16(5):561-8. PubMed ID: 9779303
[TBL] [Abstract][Full Text] [Related]
4. Interferon gamma and tumor necrosis factor alpha induce Fas expression and anti-Fas mediated apoptosis in a salivary ductal cell line.
Matsumura R; Umemiya K; Goto T; Nakazawa T; Ochiai K; Kagami M; Tomioka H; Tanabe E; Sugiyama T; Sueishi M
Clin Exp Rheumatol; 2000; 18(3):311-8. PubMed ID: 10895367
[TBL] [Abstract][Full Text] [Related]
5. Enhanced expression of programmed death-1 (PD-1)/PD-L1 in salivary glands of patients with Sjögren's syndrome.
Kobayashi M; Kawano S; Hatachi S; Kurimoto C; Okazaki T; Iwai Y; Honjo T; Tanaka Y; Minato N; Komori T; Maeda S; Kumagai S
J Rheumatol; 2005 Nov; 32(11):2156-63. PubMed ID: 16265694
[TBL] [Abstract][Full Text] [Related]
6. Involvement of the interferon-gamma-induced T cell-attracting chemokines, interferon-gamma-inducible 10-kd protein (CXCL10) and monokine induced by interferon-gamma (CXCL9), in the salivary gland lesions of patients with Sjögren's syndrome.
Ogawa N; Ping L; Zhenjun L; Takada Y; Sugai S
Arthritis Rheum; 2002 Oct; 46(10):2730-41. PubMed ID: 12384933
[TBL] [Abstract][Full Text] [Related]
7. Expression of ductal Fas antigen in sialoadenitis of Sjögren's syndrome.
Matsumura R; Kagami M; Tomioka H; Tanabe E; Sugiyama T; Sueishi M; Nakajima A; Azuma M; Okumura K
Clin Exp Rheumatol; 1996; 14(3):309-11. PubMed ID: 8809447
[TBL] [Abstract][Full Text] [Related]
8. Expression of costimulatory molecules CD80 and CD86 and their receptors CD28, CTLA-4 on malignant ascites CD3+ tumour-infiltrating lymphocytes (TIL) from patients with ovarian and other types of peritoneal carcinomatosis.
Melichar B; Nash MA; Lenzi R; Platsoucas CD; Freedman RS
Clin Exp Immunol; 2000 Jan; 119(1):19-27. PubMed ID: 10606960
[TBL] [Abstract][Full Text] [Related]
9. Expression of TNF-related apoptosis inducing ligand (TRAIL) on infiltrating cells and of TRAIL receptors on salivary glands in patients with Sjögren's syndrome.
Matsumura R; Umemiya K; Kagami M; Tomioka H; Tanabe E; Sugiyama T; Sueishi M; Kayagaki N; Yagita H; Okumura K
Clin Exp Rheumatol; 2002; 20(6):791-8. PubMed ID: 12508770
[TBL] [Abstract][Full Text] [Related]
10. Costimulatory molecules in human periodontal disease tissues.
Gemmell E; McHugh GB; Grieco DA; Seymour GJ
J Periodontal Res; 2001 Apr; 36(2):92-100. PubMed ID: 11327084
[TBL] [Abstract][Full Text] [Related]
11. Treatment with anti-CD86 costimulatory molecule prevents the autoimmune lesions in murine Sjögren's syndrome (SS) through up-regulated Th2 response.
Saegusa K; Ishimaru N; Yanagi K; Haneji N; Nishino M; Azuma M; Saito I; Hayashi Y
Clin Exp Immunol; 2000 Feb; 119(2):354-60. PubMed ID: 10632675
[TBL] [Abstract][Full Text] [Related]
12. Altered expression of costimulatory molecules in myasthenia gravis.
Teleshova N; Matusevicius D; Kivisäkk P; Mustafa M; Pirskanen R; Link H
Muscle Nerve; 2000 Jun; 23(6):946-53. PubMed ID: 10842273
[TBL] [Abstract][Full Text] [Related]
13. Expression of B7 costimulatory molecules by salivary gland epithelial cells in patients with Sjögren's syndrome.
Manoussakis MN; Dimitriou ID; Kapsogeorgou EK; Xanthou G; Paikos S; Polihronis M; Moutsopoulos HM
Arthritis Rheum; 1999 Feb; 42(2):229-39. PubMed ID: 10025916
[TBL] [Abstract][Full Text] [Related]
14. T lymphocyte subsets of the infiltrating cells in the salivary gland and kidney of a patient with Sjögren's syndrome associated with interstitial nephritis.
Takaya M; Ichikawa Y; Shimizu H; Uchiyama M; Taniguchi R; Tomino Y; Arimori S
Clin Exp Rheumatol; 1985; 3(3):259-63. PubMed ID: 3876902
[TBL] [Abstract][Full Text] [Related]
15. Tumor necrosis factor-alpha and receptors for it in labial salivary glands in Sjögren's syndrome.
Koski H; Janin A; Humphreys-Beher MG; Sorsa T; Malmström M; Konttinen YT
Clin Exp Rheumatol; 2001; 19(2):131-7. PubMed ID: 11326474
[TBL] [Abstract][Full Text] [Related]
16. Costimulatory molecules CD80 and CD86 in human crescentic glomerulonephritis.
Wu Q; Jinde K; Endoh M; Sakai H
Am J Kidney Dis; 2003 May; 41(5):950-61. PubMed ID: 12722029
[TBL] [Abstract][Full Text] [Related]
17. Sjögren's syndrome-like autoimmune sialadenitis in MRL-Faslpr mice is associated with expression of glucocorticoid-induced TNF receptor-related protein (GITR) ligand and 4-1BB ligand.
Saito K; Mori S; Date F; Ono M
Autoimmunity; 2013 Jun; 46(4):231-7. PubMed ID: 23301790
[TBL] [Abstract][Full Text] [Related]
18. Dysregulated co-stimulatory molecule expression in a Sjögren's syndrome mouse model with potential implications by microRNA-146a.
Gauna AE; Park YJ; Nayar G; Onate M; Jin JO; Stewart CM; Yu Q; Cha S
Mol Immunol; 2015 Dec; 68(2 Pt C):606-16. PubMed ID: 26505653
[TBL] [Abstract][Full Text] [Related]
19. Changes in the number of CD80(+), CD86(+), and CD28(+) peripheral blood lymphocytes have prognostic value in melanoma patients.
Martínez-Escribano JA; Hernández-Caselles T; Campillo JA; Campos M; Frías JF; García-Alonso A; Alvarez-López MR
Hum Immunol; 2003 Aug; 64(8):796-801. PubMed ID: 12878358
[TBL] [Abstract][Full Text] [Related]
20. Ductal cells of minor salivary glands in Sjögren's syndrome express LINE-1 ORF2p and APOBEC3B.
Kalogirou EM; Piperi EP; Tosios KI; Tsiambas E; Fanourakis G; Sklavounou A
J Oral Pathol Med; 2018 Feb; 47(2):179-185. PubMed ID: 29057505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
